HopeStage
Back to all studies
RecruitingNCT07550881

Nasal dexmedetomidine for acute anxiety in adults

About this titleRead the official source — NCT07550881

This study evaluates the safety and effectiveness of Dexmedetomidine for people with anxiety.

Medication studyAges 18–65China
The study in practice

Understand this study

What is this study about?

This study evaluates the safety and effectiveness of Dexmedetomidine for people with anxiety.

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
ShanghaiSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 30, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
150
Sponsor
Tongji University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT07550881
Official title
Show the full official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating the Efficacy and Safety of Dexmedetomidine Hydrochloride Nasal Spray for the Treatment of Acute Anxiety States in Adults

Recruitment & locations

Currently recruiting

Shanghai

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the safety and effectiveness of Dexmedetomidine for people with anxiety.

Who is behind this study?

The study sponsor is Tongji University, a university.

Does this study involve medication?

Yes. The study involves medication, including Dexmedetomidine.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies